CCL21 and hepatocellular carcinoma: The predictive performance of the risk score was assessed based on time-dependent ROC curves, with AUC values of 0.75, 0.67, and 0.68 for 1, 2, and 3 years, respectively (Figure 6(e)), indicating that patients with HCC were accurately predicted to survive by the SLC-gene-based signature.